| 000 | 01832cam a2200505 a 4500 | ||
|---|---|---|---|
| 005 | 20250919002734.0 | ||
| 008 | 150312s2013 stka b 001 0 eng | ||
| 020 |
_a9780702042904 _cRM125.80 |
||
| 020 | _a0702042900 | ||
| 020 | _a9780702042911 (International) | ||
| 020 | _a0702042919 (International) | ||
| 020 | _a9780702053931 (eBook) | ||
| 020 | _a0702053937 (eBook) | ||
| 039 | 9 |
_a201503300954 _bzainol _y03-12-2015 _zfashihah |
|
| 040 |
_dUKM _erda |
||
| 090 | _aQV786.A924 2013 9 | ||
| 090 |
_aQV786 _b.A924 2013 9 |
||
| 245 | 0 | 0 |
_aAulton's pharmaceutics : _bthe design and manufacture of medicines / _cedited by Michael E. Aulton and Kevin M.G. Taylor. |
| 246 | 1 | _aPharmaceutics | |
| 250 | _aFourth edition. | ||
| 264 | 1 |
_aEdinburgh ; _aNew York : _bChurchill Livingstone/Elsevier, _c2013. |
|
| 300 |
_axiii, 894 p. : _billustration ; _c25 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 2 | _aDosage Forms. | |
| 650 | 2 |
_aBiopharmaceutics _xmethods. |
|
| 650 | 2 |
_aDrug Compounding _xmethods. |
|
| 650 | 2 | _aDrug Design. | |
| 650 | 0 | 7 |
_aArzneimitteldesign. _0(DE-588)4278218-1 _2gnd |
| 650 | 0 | 7 |
_aBiologika. _0(DE-588)7689632-8 _2gnd |
| 650 | 0 | 7 |
_aPharmazeutische Technologie. _0(DE-588)4045699-7 _2gnd |
| 650 | 7 |
_aDrugs _xDesign. _2fast _0(OCoLC)fst00898790 |
|
| 650 | 7 |
_aDrugs _xDosage forms. _2fast _0(OCoLC)fst00898801 |
|
| 700 | 1 | _aAulton, Michael E. | |
| 700 | 1 |
_aTaylor, Kevin, _d1961- |
|
| 907 |
_a.b16093501 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV786.A924 2013 9 |
||
| 914 | _avtls003580808 | ||
| 991 | _aPerpustakaan Dr. Abdul Latiff, KKL | ||
| 998 |
_ad _b2015-12-03 _cm _da _feng _gstk _y0 _z.b16093501 |
||
| 999 |
_c588424 _d588424 |
||